Hikma Pharmaceuticals (HKMPY)

PNK: HKMPY · Real-Time Price · USD

53.81

0.84 (1.59%)

At close: May 02, 2025, 3:45 PM

Hikma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	455M	281M	233M	544M	558M	491M	293M	-738M	210M
Depreciation & Amortization	197M	198M	193M	145M	91M	99M	121M	1.24B	146M
Stock-Based Compensation	27M	25M	22M	29M	27M	24M	21M	22M	22M
Other Working Capital	121M	131M	-49M	84M	13M	-34M	-21M	-4M	19M
Other Non-Cash Items	20M	24M	213M	39M	22M	1M	77M	-9M	86M
Deferred Income Tax	n/a	n/a	n/a	-89M	-26M	-99M	-57M	-105M	-76M
Change in Working Capital	-135M	80M	-131M	-30M	-208M	-44M	-25M	32M	-95M
Operating Cash Flow	564M	608M	530M	638M	464M	472M	430M	443M	293M
Capital Expenditures	-235M	-204M	-225M	-229M	-224M	-186M	-139M	-151M	-190M
Cash Acquisitions	-162M	-105M	-380M	-17M	-60M	19M	27M	5M	-515M
Purchase of Investments	-2M	-27M	-15M	-3M	-5M	-6M	-4M	-10M	-17M
Sales Maturities Of Investments	n/a	1M	n/a	6M	2M	14M	4M	-37M	-30M
Other Investing Acitivies	-52M	-33M	13M	5M	4M	8M	16M	42M	57M
Investing Cash Flow	-381M	-333M	-607M	-238M	-283M	-151M	-96M	-151M	-695M
Debt Repayment	124M	-93M	456M	-83M	234M	2M	-141M	-78M	153M
Common Stock Repurchased	n/a	n/a	-300M	n/a	-375M	n/a	n/a	n/a	n/a
Dividend Paid	-175M	-137M	-125M	-120M	-109M	-97M	-84M	-79M	-77M
Other Financial Acitivies	-99M	-107M	-89M	-84M	-48M	-60M	-53M	-63M	-57M
Financial Cash Flow	-188M	-337M	-58M	-287M	-298M	-155M	-278M	-220M	19M
Net Cash Flow	-17M	-65M	-156M	103M	-119M	166M	49M	72M	-398M
Free Cash Flow	329M	404M	305M	409M	240M	286M	291M	292M	103M